Fundraising Fox

Pappas Capital

Venture capital

Research Triangle Park · Seed–Late Stage · 15 people tracked

Also known as A.M. Pappas & Associates, LLC · PAPPAS CAPITAL, LLC

Find your way into Pappas Capital

2,069 people in our graph share verified history with the Pappas Capital team — schools, employers, funds. One of them is your warm intro.

Harley Finkelsteinunlockedknows Anthony P. Lee · together at C100 Association (overlapped)
knows the team · via C100 Association
×2knows the team · via McKinsey & Company
×2knows the team · via Duke University
×2knows the team · via UNC Kenan-Flagler Business School
×2knows the team · via EBS Universität für Wirtschaft und Recht
Fox Verdict
Sign up to see your fit

Investment thesis

Pappas Capital focuses on the life sciences, investing in and building innovative companies that develop next-generation life science products and technologies. Over more than three decades it has backed over 100 companies across the United States, Canada, and Asia, spanning the full range of human disease. Its portfolio companies have brought to market products treating conditions such as melanoma, ovarian cancer, and hemophilia, which have been used worldwide to treat tens of thousands of patients and generated billions of dollars in revenue. The firm offers both capital and operational expertise to founders building life science businesses.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
Check
$100K – $6M
HQ
Research Triangle Park, North Carolina, US
Instruments
Equity
Founded
1994
AUM
$800M
VC funds
8
Tracked investments
12
IPOs
1

Team · 15 people

from curated & public directories

What they invest in

from 12 of 12 portfolio companies

Biotech ×7Healthtech ×7Medical Devices ×3Climate Tech ×2AI & Machine Learning ×1Cleantech ×1Cloud Computing ×1Consumer ×1

HQs:United States×5Germany×1Singapore×1Vietnam×1

Investments · 12 tracked

founders shown can be your intro path

By year:2025 · 12022 · 22021 · 12020 · 22017 · 17 dated

Aktis Oncologyaktisoncology.cominNASDAQ: AKTSAug 2022

Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.

BiotechHealthtechMedical DevicesBoston, US

Todd Foley(Co-founder and Chairman)inPatrick Baeuerle(Co-founder & Advisor)inShulamit Ron-Bigger(Executive Officer)inKyle D. Kuvalanka(Chief Financial Officer)inAkos Czibere(Chief Medical Officer)inPaul L. Feldman(Chief Scientific Officer)in

Co-investorsAndreessen HorowitzEcoR1 CapitalMPM BioImpactMRL Ventures FundRA CapitalTCG Crossover+4 more

Curasencurasen.com✓ verified

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.

BiotechHealthtech

Anthony Fordin

Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCNew Leaf Venture Partners+2 more

Sorriso Pharmaceuticalssorrisopharma.cominDec 2021✓ verified

Sorriso Pharma is a biopharmaceutical company backed by leading venture capital firms specializing in life sciences and healthcare investments.

BiotechHealthtechMedical DevicesSandy, US

Ciara Kennedy, Ph.D.(Executive Officer, Director)Brian Dorsey(Executive Officer)Michael Grey(Director)Mark Chin(Director)Susan Dube(Executive Officer)

BoardEdward Mathers(Director)

Co-investorsNew Enterprise Associates (NEA)NEA Secondary

Reneoreneo.deinDec 2020 · $95M

Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.

Climate TechEnterprise SoftwarePropTechGermany, DE

Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in

Co-investorsFoundamentalAbingworthAisling CapitalAmzak HealthEurazeoLakestar+4 more

Reneo Pharmaceuticalsreneopharma.comDec 2020 · $95M

Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.

ConsumerMedia & EntertainmentSports Tech

Co-investorsAisling CapitalNew Enterprise Associates (NEA)AbingworthAmzak HealthLundbeckfonden VenturesRiverVest Venture Partners+1 more

Ribometrixribometrix.com

BiotechGreenville, US

Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Co-investorsHatteras Venture PartnersIllumina VenturesM VenturesMC Healthcare VenturesPappas CapitalSV Health Investors+1 more

Rotation Medicalrotationmedical.com

HealthtechPlymouth, US

Thomas Westling(Executive Officer, Director)inMartha Shadan(Executive Officer, Director)Randy Nuernberg(Executive Officer)Craig Van Kampen(Executive Officer)

BoardFouad Azzam(Director)inScott Weiner(Director)in

Co-investorsNew Enterprise Associates (NEA)

Solusolu.bioin𝕏

Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration.

BiotechCloud ComputingHealthtech

Sam Sihvonen(Founder)in

Co-investorsLifeline VenturesWave Ventures

Solusolutherapeutics.comin𝕏

Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels.

BiotechHealthtech

Phil Vickers(CEO / Leadership)inMichael Boretti(Leadership)inBrandon Turunen(Leadership)inSergio Santillana(Leadership)Enda Moran(Leadership)inKelly Honohan(Leadership)in

Co-investorsAstellas Venture Management LLCLongwood Fund

Us2us2.aiin𝕏Apr 2022

Us2.ai provides FDA-cleared AI software that automatically analyzes echocardiograms and generates structured clinical reports in real time.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsEast Post Road VenturesPartech VenturesPeak XV Partners

VFlowTechvflowtech.cominMay 2025 · $20.5M

VFlowTech develops PowerCube vanadium flow battery energy storage systems for commercial, industrial, grid and distributed generation applications in the renewable energy market.

CleantechClimate TechEnergyHardwareSingapore, SG

Avishek Kumar(CEO)inArjun Bhattarai(CTO)in

Co-investorsEntrepreneur FirstUntroD CapitalAntares Ventures Pte. Ltd.Granite AsiaMOL PLUSSEEDS Capital+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

OrphoMed

Exits · 1

1 IPOs

Aktis OncologyNASDAQ: AKTS

Portfolio news

latest coverage across their companies

Public market activity · per SEC filings

what is this? ⓘ
SC 13D/A filingSC 13D/A

Disclosed stake · filed Feb 2016

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2016

view filing ↗
SC 13D filingSC 13D

Disclosed stake · filed Feb 2016

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2015

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Mar 2014

view filing ↗
SC 13G/A filingSC 13G/A

Disclosed stake · filed Feb 2014

view filing ↗
SC 13G filingSC 13G

Disclosed stake · filed Nov 2012

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Jul 2011

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed May 2011

view filing ↗
SC 13D filingSC 13D

Disclosed stake · filed Aug 2010

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Mar 2006

view filing ↗
SC 13D/A filingSC 13D/A

Disclosed stake · filed Dec 2005

view filing ↗

14 insider ownership filings (Forms 3/4/5)

From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.

Frequently asked questions

How many investments has Pappas Capital made?
Pappas Capital has 12 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does Pappas Capital invest at?
Pappas Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
What is Pappas Capital's typical check size?
Pappas Capital typically writes checks of $100K – $6M.
What sectors does Pappas Capital focus on?
Pappas Capital focuses on Biotech, Healthtech, Medical Devices.
Where is Pappas Capital located?
Pappas Capital is headquartered in Research Triangle Park, US.

Images

Pappas Capital photo

Co-investors · 6

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

$200K – $40M
Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M
Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M
EQT Life Sciences

EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.

$11M – $66M
Avoro Capital Advisors

Avoro Capital Advisors is an investment firm focused on healthcare and life sciences, pursuing scientific breakthroughs that address unmet medical needs.

Amplitude Venture Capital

Amplitude Venture Capital is a Canadian venture firm that creates, builds, and grows precision medicine companies aimed at improving patient outcomes.

Firms observed investing alongside Pappas Capital, from public investor directories. Shared companies are the overlap with Pappas Capital's recorded portfolio.

Similar investors

Featured in lists